Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasis

por Voak, Andrew A., Harris, Andy, Coteron-Lopez, Jose Miguel, Angulo-Barturen, Iñigo, Ferrer-Bazaga, Santiago, Croft, Simon L., Seifert, Karin
Publicado 2021

Repurposing clinically approved cephalosporins for tuberculosis therapy

por Ramón-García, Santiago, González del Río, Rubén, Villarejo, Angel Santos, Sweet, Gaye D., Cunningham, Fraser, Barros, David, Ballell, Lluís, Mendoza-Losana, Alfonso, Ferrer-Bazaga, Santiago, Thompson, Charles J.
Publicado 2016

Repositioning: the fast track to new anti-malarial medicines?

por Lotharius, Julie, Gamo-Benito, Francisco Javier, Angulo-Barturen, Iñigo, Clark, Julie, Connelly, Michele, Ferrer-Bazaga, Santiago, Parkinson, Tanya, Viswanath, Pavithra, Bandodkar, Balachandra, Rautela, Nikhil, Bharath, Sowmya, Duffy, Sandra, Avery, Vicky M, Möhrle, Jörg J, Guy, R Kiplin, Wells, Timothy
Publicado 2014

A novel class of fast‐acting antimalarial agents: Substituted 15‐membered azalides

por Peric, Mihaela, Pešić, Dijana, Alihodžić, Sulejman, Fajdetić, Andrea, Herreros, Esperanza, Gamo, Francisco Javier, Angulo‐Barturen, Iñigo, Jiménez‐Díaz, María Belén, Ferrer‐Bazaga, Santiago, Martínez, María S., Gargallo‐Viola, Domingo, Mathis, Amanda, Kessler, Albane, Banjanac, Mihailo, Padovan, Jasna, Bencetić Mihaljević, Vlatka, Munic Kos, Vesna, Bukvić, Mirjana, Eraković Haber, Vesna, Spaventi, Radan
Publicado 2020

Determination of the Pharmacokinetics and Pharmacodynamics of Isoniazid, Rifampicin, Pyrazinamide and Ethambutol in a Cross-Over Cynomolgus Macaque Model of Mycobacterium tuberculo...

por Sibley, Laura, White, Andrew D., Sarfas, Charlotte, Gullick, Jennie, Gleeson, Fergus, Lanni, Faye, Clark, Simon, Rayner, Emma, Ferrer-Bazaga, Santiago, Ortega-Muro, Fatima, Alameda, Laura, Rullas, Joaquin, Sousa, Veronica, Martinez, Marisa, Angulo-Barturen, Inigo, Garcia, Adolfo, Vaquero, Juan José, Pertinez, Henry E., Davies, Geraint, Dennis, Mike, Williams, Ann, Sharpe, Sally
Publicado 2022

Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor

por Martínez-Hoyos, María, Perez-Herran, Esther, Gulten, Gulcin, Encinas, Lourdes, Álvarez-Gómez, Daniel, Alvarez, Emilio, Ferrer-Bazaga, Santiago, García-Pérez, Adolfo, Ortega, Fátima, Angulo-Barturen, Iñigo, Rullas-Trincado, Joaquin, Blanco Ruano, Delia, Torres, Pedro, Castañeda, Pablo, Huss, Sophie, Fernández Menéndez, Raquel, González del Valle, Silvia, Ballell, Lluis, Barros, David, Modha, Sundip, Dhar, Neeraj, Signorino-Gelo, François, McKinney, John D., García-Bustos, Jose Francisco, Lavandera, Jose Luis, Sacchettini, James C., Jimenez, M. Soledad, Martín-Casabona, Nuria, Castro-Pichel, Julia, Mendoza-Losana, Alfonso
Publicado 2016

A novel multiple-stage antimalarial agent that inhibits protein synthesis

por Baragaña, Beatriz, Hallyburton, Irene, Lee, Marcus C. S., Norcross, Neil R., Grimaldi, Raffaella, Otto, Thomas D., Proto, William R., Blagborough, Andrew M., Meister, Stephan, Wirjanata, Grennady, Ruecker, Andrea, Upton, Leanna M., Abraham, Tara S., Almeida, Mariana J., Pradhan, Anupam, Porzelle, Achim, Martínez, María Santos, Bolscher, Judith M., Woodland, Andrew, Norval, Suzanne, Zuccotto, Fabio, Thomas, John, Simeons, Frederick, Stojanovski, Laste, Osuna-Cabello, Maria, Brock, Paddy M., Churcher, Tom S., Sala, Katarzyna A., Zakutansky, Sara E., Jiménez-Díaz, María Belén, Sanz, Laura Maria, Riley, Jennifer, Basak, Rajshekhar, Campbell, Michael, Avery, Vicky M., Sauerwein, Robert W, Dechering, Koen J., Noviyanti, Rintis, Campo, Brice, Frearson, Julie A., Angulo-Barturen, Iñigo, Ferrer-Bazaga, Santiago, Gamo, Francisco Javier, Wyatt, Paul G., Leroy, Didier, Siegl, Peter, Delves, Michael J., Kyle, Dennis E., Wittlin, Sergio, Marfurt, Jutta, Price, Ric N., Sinden, Robert E., Winzeler, Elizabeth, Charman, Susan A., Bebrevska, Lidiya, Gray, David W., Campbell, Simon, Fairlamb, Alan H., Willis, Paul, Rayner, Julian C., Fidock, David A., Read, Kevin D., Gilbert, Ian H.
Publicado 2015